KWMG
ONC

King Wealth Management Group’s BeOne Medicines Ltd ONC Stock Holding History

King Wealth Management Group’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,000
Closed -$540K – 150
2023
Q3 		$540K Hold
3,000
– – 0.11% 75
2023
Q2 		$535K Hold
3,000
– – 0.11% 76
2023
Q1 		$647K Hold
3,000
– – 0.14% 67
2022
Q4 		$660K Buy
+3,000
New +$550K 0.16% 68

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

King Wealth Management Group's ONC Position: Q4 2023 in Review

King Wealth Management Group sold out of BeOne Medicines Ltd (ONC) in Q4 2023, closing a stake of 3,000 shares — an estimated $540K sold.

King Wealth Management Group first reported a position in ONC in Q4 2022 and held it in 4 quarters. The position peaked at $660K in Q4 2022. 204 funds tracked by Wall St. Rank hold ONC as of Q4 2023.

  • King Wealth Management Group reported no remaining BeOne Medicines Ltd position as of Q4 2023 after selling out during the quarter.
  • King Wealth Management Group sold 3,000 BeOne Medicines Ltd shares in Q4 2023, an estimated $540K.
  • King Wealth Management Group first reported a position in BeOne Medicines Ltd in Q4 2022 and held it in 4 quarters.
  • King Wealth Management Group's BeOne Medicines Ltd position peaked at $660K in Q4 2022.
  • 204 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2023.

Based on King Wealth Management Group's 13F filing for Q4 2023, filed 8 Feb 2024.